Miguel Angel
Canales Albendea
Consultor Médico
Francisco Javier
Capote Huelva
Francisco Javier Capote Huelva-rekin lankidetzan egindako argitalpenak (1)
2019
-
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial
Cancer Medicine, Vol. 8, Núm. 16, pp. 6955-6966